PIRS - Pieris Pharmaceuticals EPS beats by $0.10 beats on revenue May, 17 2021 07:02 AM Pieris Pharmaceuticals Inc. Pieris Pharmaceuticals (PIRS): Q1 GAAP EPS of -$0.07 beats by $0.10.Revenue of $15.63M (+17.9% Y/Y) beats by $9.93M.Press Release For further details see: Pieris Pharmaceuticals EPS beats by $0.10, beats on revenue